AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 3 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 8.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $272,000 | +532.6% | 25,694 | +340.5% | 0.01% | +250.0% |
| Q1 2017 | $43,000 | -90.5% | 5,833 | -94.4% | 0.00% | -93.8% |
| Q4 2016 | $451,000 | -32.1% | 103,585 | 0.0% | 0.03% | -25.6% |
| Q3 2016 | $664,000 | +28.9% | 103,585 | -2.2% | 0.04% | +19.4% |
| Q2 2016 | $515,000 | – | 105,893 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 20,592 | $347,798 | 24.67% |
| VR Adviser, LLC | 295,034 | $3,614,167 | 0.38% |
| IFP Advisors, Inc | 2,860 | $1,718 | 0.00% |